Umberto Campia

[Aaron Paul Kithcart @APKithcartMDPhD]

A third of LGBT adults report being treated unfairly by health care professionals. These patients are less likely to seek medical care, leading to worse health care outcomes. We have to do a better job treating ALL patients with respect. https://t.co/AO7RE5j4ct

[Darryl Leong @DarrylLeong]

Always great to hear the erudite ⁦@TomasNeilan⁩ speak on #ici #myocarditis #mskcardioonccme

[Marc Carrier @MarcCarrier1]

Can Factors XI inhibitors address the persisting unmet needs in the management of cancer-associated thrombosis (e.g., ↑ risk of bleeding in some tumor types, drug-drug interactions, renal impairment, etc.)? Great review by @TzufeiWang in @OncJournal
https://t.co/d8PabBITsk

[Darryl Leong @DarrylLeong]

Do ICIs still work if steroids are needed? Important #cardioonc permissive cardiotoxicity question. #MSKcardiooncCME

[Kristine Jang @Kristinehjang]

Wonderful talk on the role of GLS in cardio-oncology by the one and only @JLiu_MSKCardOnc #MSKCardioOncCME #MSKCME

[Ana Barac, MD, PhD, FACC, FAHA @AnaBaracCardio]

Are we Ready? Less frequent monitoring for low risk patients & More CV-risk guided imaging in patients at high risk for cardiotoxicity. Great examples of How to do it? by Dr Anthony Yu and Dr Chau Dang @JLiu_MSKCardOnc #MSKCardioOncCME @sdent_duke

[Umberto Campia @u_campia]

Great panel at #MSKCardioOncCME symposium!!

[Darryl Leong @DarrylLeong]

Superb overview of #CIED considerations in patients who need #radiotherapy by @Dr_Mike_Fradley #MSCKCardioOncCME

[Mike Fradley, MD @Dr_Mike_Fradley]

Brilliant overview of CML cardiotoxicity by @husam247 #cardioonc #leusm #mskcardioonccme

[Umberto Campia @u_campia]

Amazing talk on cardioprotective strategies to prevent cardiotoxicity by Dr. Ana Barac
#MSKCardioOncCME

[Ana Barac, MD, PhD, FACC, FAHA @AnaBaracCardio]

Terrific summary of progress in cardio-oncology clinical trials by Dr Anju Nohria #MSKCardioOncCME and great discussion on where to go next @JLiu_MSKCardOnc @mariellesc1 @TomasNeilan @BrighamWomens @IHVInews

[Ana Barac, MD, PhD, FACC, FAHA @AnaBaracCardio]

Inspiring presentation by always visionary @MathewMaurer on the current state and future in ATTR cardiac amyloidosis. With spectacular panel and discussion @JLiu_MSKCardOnc

[Umberto Campia @u_campia]

@chelseahandler That’s so true!!

[Ana Barac, MD, PhD, FACC, FAHA @AnaBaracCardio]

#ACCCardioOnc Learning

[Aaron Paul Kithcart @APKithcartMDPhD]

Dr. @GerhardHerman educates us at our morning Vascular Medicine conference, teaching us about the many roadblocks to diagnosing PAD. She should know, she wrote the guidelines! #VascularDisease @BrighamWomens

[AHAMeetings @AHAMeetings]

Remember to pack #redshoes or #redsocks for #VascularDiscovery18! Pls RT! @AHAScience @ATVBCouncil @GenPrecisionMed @atvbahajournals @Circ_Gen @isth @VeinForum @MaryCushmanMD @JoshuaBeckmanMD @GBarnesMD @American_Heart @beardbride @NaomiHamburg @EstherSHKimMD @u_campia @IowaMSTP

[Naomi Hamburg @NaomiHamburg]

@AHAMeetings @AHAScience @ATVBCouncil @GenPrecisionMed @atvbahajournals @Circ_Gen @isth @VeinForum @MaryCushmanMD @JoshuaBeckmanMD @GBarnesMD @American_Heart @beardbride @EstherSHKimMD @u_campia @IowaMSTP Red shoes on 👠!

[Javid Moslehi @CardioOncology]

Excellent piece by @noka_oi in Cancer Today @CancerTodayMag on vascular aspects of cardio-oncology #CardioOnc yes, the field of cardio-oncology goes beyond Heart failure. Time to bring vascular med docs to the field @heatherlgornik @SVM_tweets @VMJ_SVM

[Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @DrMarthaGulati]

And we should do this publicly for all industry. Not just actors. Medicine, healthcare, corporations. Let’s be vocal about it and make it change #TimesUp https://t.co/muFmv8V8fi

[VascularMedicine @VMJ_SVM]

Dec 2017 Patient Page reviews Antiphospholipid Antibodies by @StephenMoll https://t.co/wm5Strbo7e @LupusOrg @APSFA #FREE